Novelty Hand Sanitizer With Silicone Wrap Sku 998890 Novelty Hand Sanitizer Ass shortage — US supply status & alternatives

Novelty Hand Sanitizer With Silicone Wrap Sku 998890 Novelty Hand Sanitizer Ass

—

In supply · Australia

Novelty Hand Sanitizer with Silicone Wrap SKU

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Novelty Hand Sanitizer With Silicone Wrap Sku 998890 Novelty Hand Sanitizer Ass
Brand names	Novelty Hand Sanitizer with Silicone Wrap SKU
Therapeutic category	Auto-created by FDA MedWatch — Drug Safety Alerts scraper
Controlled substance	No
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 1d ago

High

Recalls official enforcement reports

🇺🇸

Novelty Hand Sanitizer With Silicone Wrap Sku 998890 Novelt

Family Dollar Stores, Llc. · June 2022

Class IIdetails ↗

Verified timeline regulator events

🇺🇸 23 June 2022

high reported

Sources official regulators

🇺🇸

FDA MedWatch

verified 1d ago

verify ↗

Mederti Drug Report

Generated 1 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.